Furthermore, syntaxin binding protein 5 (STXBP5), identified as a potential target of hsa-miR-12136, has been linked to venous thromboembolism, a condition characterized by the formation of blood clots, secondary vascular changes, and altered hemodynamics (Zhu et al., 2014). Here, STXBP5 is linked to venous thromboembolism.